Disc Medicine Inc at TD Cowen Healthcare Conference Transcript
Hi everyone, good morning. I'm Tara Bancroft. I'm one of the senior biotech analysts here at Cowan, and thank you for coming to TD Cowan's 46th annual healthcare conference. So for our next session we have a presentation and some Q&A from DISC Medicine, and from DISC we have the CEO John Quizzle.
Thank you so much for joining us today. We really look forward to the discussion. So why don't you go ahead with your presentation, and I'll come back for Q&A.
Great, thank you.
Great to be here. I really appreciate the opportunity to speak here. Turns out to be, I think, a valuable moment for some communication.
So let's see, I will just note that there's going to be some forward-looking statements. Those should all be taken into account with the things that we filed with the SEC and on our website.
And then we'll be talking about 3 different clinical stage programs, none of which are approved in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
